Follow
Peter Bader
Peter Bader
Unknown affiliation
Verified email at kgu.de
Title
Cited by
Cited by
Year
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ...
New England Journal of Medicine 378 (5), 439-448, 2018
45582018
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
VHJ Van der Velden, G Cazzaniga, A Schrauder, J Hancock, P Bader, ...
Leukemia 21 (4), 604-611, 2007
8372007
Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ...
Journal of Clinical Oncology 34 (36), 4381-4389, 2016
5732016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 51 (6), 786-792, 2016
5552016
Determinants of antileukemia effects of allogeneic NK cells
W Leung, R Iyengar, V Turner, P Lang, P Bader, P Conn, D Niethammer, ...
The Journal of Immunology 172 (1), 644-650, 2004
5462004
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ...
Bone marrow transplantation 50 (8), 1037-1056, 2015
4652015
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 51 (7), 906-912, 2016
4282016
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM …
P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ...
Journal of Clinical Oncology 27 (3), 377-384, 2009
4252009
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
E Gluckman, B Cappelli, F Bernaudin, M Labopin, F Volt, J Carreras, ...
Blood, The Journal of the American Society of Hematology 129 (11), 1548-1556, 2017
4182017
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ...
Bone marrow transplantation 52 (6), 811-817, 2017
4042017
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
S Corbacioglu, S Cesaro, M Faraci, D Valteau-Couanet, B Gruhn, ...
The Lancet 379 (9823), 1301-1309, 2012
3982012
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 50 (6), 781-789, 2015
3882015
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial
F Locatelli, P Nöllke, M Zecca, E Korthof, E Lanino, C Peters, A Pession, ...
Blood 105 (1), 410-419, 2005
3762005
Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children
R Handgretinger, T Klingebiel, P Lang, M Schumm, S Neu, A Geiselhart, ...
Bone marrow transplantation 27 (8), 777-783, 2001
3442001
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation …
P Bader, H Kreyenberg, W Hoelle, G Dueckers, R Handgretinger, P Lang, ...
Journal of clinical oncology 22 (9), 1696-1705, 2004
3192004
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ...
Bone marrow transplantation 54 (10), 1525-1552, 2019
3172019
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and …
S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ...
Bone marrow transplantation 53 (2), 138-145, 2018
2952018
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 50 (4), 476-482, 2015
2902015
How and when should we monitor chimerism after allogeneic stem cell transplantation?
P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel
Bone marrow transplantation 35 (2), 107-119, 2005
2882005
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
H Einsele, H Hebart, C Kauffmann-Schneider, C Sinzger, G Jahn, P Bader, ...
Bone marrow transplantation 25 (7), 757-763, 2000
2842000
The system can't perform the operation now. Try again later.
Articles 1–20